X‑Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
LONDON and HYDERABAD, India; Feb. 9, 2022 – A new collaboration between data science and analytics leader, Excelra, and artificial...
GHO Capital Acquires X‑Chem, the Leading Provider of DNA-Encoded-Library-Mediated Drug Discovery Services
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, announces the acquisition of X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, from an affiliate of The Carlyle Group and Hellman & Friedman LLC.
Does Size Matter in DEL Screening?
One of the most attractive aspects of DNA-encoded library (DEL) technology is the vast number of compounds that can be...
X‑Chem acquires IntelliSyn and sister company, AviSyn, to extend and streamline drug discovery service range
Acquisition allows X-Chem to offer a more comprehensive, integrated, screen-to-lead drug discovery process to pharma and biotech clients IntelliSyn’s Founder...
Qui sommes-nous?
Anglais Français X-Chem est votre partenaire pour la découverte de petites molécules X-Chem est le partenaire dont vous avez besoin...
ALK-Abelló and X‑Chem Announce Drug Discovery Collaboration
WALTHAM, Mass. – February 5, 2019 - X-Chem, Inc. (X-Chem), a privately held biotechnology company focused on applying its next-generation, industry-leading DNA-Encoded library (DEXTM) drug discovery platform to the generation of novel small molecule therapeutics, announced today a drug discovery partnership with ALK-Abelló A/S (ALK), a Danish pharmaceutical company focused on the prevention and treatment of allergies. This collaboration will focus on the discovery of small molecule drug products to treat broad ranging allergies.
AI-Powered Building Blocks “ReadiBLOX” for DEL Synthesis
Drug Hunter recently wrote the article “Decoding DNA-Encoded Libraries for Drug Discovery.” Over the past two decades, DEL technology has...
Proximity Labeling: DEL Selection Without Capturing the Target
DNA-encoded library (DEL) selections typically use affinity pulldown to enrich compounds that bind targets of interest. While it is highly...